This study is in progress, not accepting new patients
A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Subjects With Crohn's Disease
a study on Crohn's Disease Inflammatory Bowel Disease
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AbbVie
- ID
- NCT02782663
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated